Exhaled breath monitoring during home ventilo-therapy in COPD patients by a new distributed tele-medicine system

Author(s):  
Antonio Vincenzo Radogna ◽  
Nicola Fiore ◽  
Maria Rosaria Tumolo ◽  
Valerio De Luca ◽  
Lucio T. De Paolis ◽  
...  
2018 ◽  
Author(s):  
T. Iton ◽  
T. Miwa ◽  
A. Tsuruta ◽  
T. Akamatsu ◽  
N. Izu ◽  
...  

Author(s):  
R. de Vries ◽  
J.M. van den Heuvel ◽  
Y.W.F. Dagelet ◽  
E. Dijkers ◽  
T. Fabius ◽  
...  

2018 ◽  
Vol 51 (1) ◽  
pp. 1701817 ◽  
Author(s):  
Rianne de Vries ◽  
Yennece W.F. Dagelet ◽  
Pien Spoor ◽  
Erik Snoey ◽  
Patrick M.C. Jak ◽  
...  

Asthma and chronic obstructive pulmonary disease (COPD) are complex and overlapping diseases that include inflammatory phenotypes. Novel anti-eosinophilic/anti-neutrophilic strategies demand rapid inflammatory phenotyping, which might be accessible from exhaled breath.Our objective was to capture clinical/inflammatory phenotypes in patients with chronic airway disease using an electronic nose (eNose) in a training and validation set.This was a multicentre cross-sectional study in which exhaled breath from asthma and COPD patients (n=435; training n=321 and validation n=114) was analysed using eNose technology. Data analysis involved signal processing and statistics based on principal component analysis followed by unsupervised cluster analysis and supervised linear regression.Clustering based on eNose resulted in five significant combined asthma and COPD clusters that differed regarding ethnicity (p=0.01), systemic eosinophilia (p=0.02) and neutrophilia (p=0.03), body mass index (p=0.04), exhaled nitric oxide fraction (p<0.01), atopy (p<0.01) and exacerbation rate (p<0.01). Significant regression models were found for the prediction of eosinophilic (R2=0.581) and neutrophilic (R2=0.409) blood counts based on eNose. Similar clusters and regression results were obtained in the validation set.Phenotyping a combined sample of asthma and COPD patients using eNose provides validated clusters that are not determined by diagnosis, but rather by clinical/inflammatory characteristics. eNose identified systemic neutrophilia and/or eosinophilia in a dose-dependent manner.


2020 ◽  
Vol 6 (3) ◽  
pp. 00361-2019
Author(s):  
Einat Klein Fireman ◽  
Yochai Adir ◽  
Elizabeth Fireman ◽  
Aharon Kessel

IntroductionParticulate matter (PM) and cigarette-related cadmium exposure increases inflammation and smokers' susceptibility to developing lung diseases. The majority of inhaled metals are attached to the surface of ultrafine particles (UFPs). A low inhaled UFP content in exhaled breath condensate (EBC) reflects a high inflammatory status of airways.MethodsEBC was collected from 58 COPD patients and 40 healthy smokers and nonsmokers. Participants underwent spirometry, diffusion capacity, EBC and blood sampling. Environmental pollution data were collected from monitoring stations. UFPs were measured in EBC and serum, and cadmium content was quantified.ResultsSubjects with low UFP concentrations in EBC (<0.18×108·mL−1) had been exposed to higher long-term PM2.5 levels versus subjects with high UFP concentrations in EBC (>0.18×108·mL−1) (21.9 µg·m−3versus 17.4 µg·m−3, p≤0.001). Long-term PM2.5 exposure levels correlated negatively with UFP concentrations in EBC and positively with UFP concentrations in serum (r=−0.54, p≤0.001 and r=0.23, p=0.04, respectively). Healthy smokers had higher cadmium levels in EBC versus healthy nonsmokers and COPD patients (25.2 ppm versus 23.7 ppm and 23.3 ppm, p=0.02 and p=0.002, respectively). Subjects with low UFP concentrations in EBC also had low cadmium levels in EBC versus subjects with high UFP levels (22.8 ppm versus 24.2 ppm, p=0.004)ConclusionsLow UFP concentration in EBC is an indicator of high-level PM exposure. High cadmium levels in EBC among smokers and the association between cadmium and UFP content in EBC among COPD patients indicate cadmium lung toxicity.


2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
Nailya Kubysheva ◽  
Larisa Postnikova ◽  
Svetlana Soodaeva ◽  
Viкtor Novikov ◽  
Tatyana Eliseeva ◽  
...  

The definition of new markers of local and systemic inflammation of chronic obstructive pulmonary disease (COPD) is one of the priority directions in the study of pathogenesis and diagnostic methods improvement for this disease. We investigated 91 patients with COPD and 21 healthy nonsmokers. The levels of soluble CD25, CD38, CD8, and HLA-I-CD8 molecules in the blood serum and exhaled breath condensate (EBC) in moderate-to-severe COPD patients during exacerbation and stable phase were studied. An unidirectional change in the content of sCD25, sCD38, and sCD8 molecules with increasing severity of COPD was detected. The correlations between the parameters of lung function and sCD8, sCD25, and sHLA-I-CD8 levels in the blood serum and EBC were discovered in patients with severe COPD. The findings suggest a pathogenetic role of the investigated soluble molecules of the COPD development and allow considering the content of sCD8, sCD25, and sHLA-I-CD8 molecules as additional novel systemic and endobronchial markers of the progression of chronic inflammation of this disease.


2009 ◽  
Vol 10 (1) ◽  
Author(s):  
Rembert Koczulla ◽  
Silvano Dragonieri ◽  
Robert Schot ◽  
Robert Bals ◽  
Stefanie A Gauw ◽  
...  

2009 ◽  
Vol 21 (1) ◽  
pp. 55-61 ◽  
Author(s):  
Kevin H. Dunn ◽  
Isabelle Devaux ◽  
Allison Stock ◽  
Luke P. Naeher

ACS Omega ◽  
2020 ◽  
Vol 5 (26) ◽  
pp. 16089-16098
Author(s):  
Guillaume L. Erny ◽  
Ricardo A. Gomes ◽  
Mónica S. F. Santos ◽  
Lúcia Santos ◽  
Nuno Neuparth ◽  
...  
Keyword(s):  

Author(s):  
Paolo Montuschi ◽  
Giuseppe Santini ◽  
Nadia Mores ◽  
Tim Higenbottam ◽  
Alessia Vignoli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document